These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33590446)

  • 1. Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
    Mangia A; Albanese AP; Bourliére M; Craxi A; Dieterich D; Solomon S; Vanstraelen K; Hernandez C; Turnes J
    Adv Ther; 2021 Mar; 38(3):1397-1403. PubMed ID: 33590446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global elimination of hepatitis C?
    Sonderup MW
    S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phases of hepatitis C elimination: achieving WHO elimination targets.
    Pedrana A; Munari S; Stoové M; Doyle J; Hellard M
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance and COVID-19: Intersections and implications.
    Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI
    Elife; 2021 Feb; 10():. PubMed ID: 33588991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs.
    Sulkowski MS; Martinez A; Tyson GL; Scholz K; Franco RA; Kohli A; Julius SF; Deming P; Fink SA; Lynch K; Roytman M; Stainbrook TR; Turner MD; Viera-Briggs M; Ramers CB
    J Viral Hepat; 2024 Jun; 31(6):342-356. PubMed ID: 38433561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts.
    Forns X; Feld JJ; Dylla DE; Pol S; Chayama K; Hou J; Heo J; Lampertico P; Brown A; Bondin M; Tatsch F; Burroughs M; Marcinak J; Zhang Z; Emmett A; Gordon SC; Jacobson IM
    Adv Ther; 2021 Jun; 38(6):3409-3426. PubMed ID: 34021887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recently acquired HCV infection in men who have sex with men in Germany in the direct-acting antivirals era and during the COVID-19 pandemic.
    Ingiliz P; Lutz T; Schewe K; Baumgarten A; Krznaric I; Mauss S; Christensen S; Bickel M; Schmidt AJ; Sabranski M; He F; Jain S; Martin NK; Rockstroh JK; Boesecke C
    HIV Med; 2024 Aug; 25(8):967-975. PubMed ID: 38812289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection.
    Scotto R; Buonomo AR; Moriello NS; Maraolo AE; Zappulo E; Pinchera B; Gentile I; Borgia G
    Rev Recent Clin Trials; 2019; 14(3):173-182. PubMed ID: 30848211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.
    Bajis S; Applegate TL; Grebely J; Matthews GV; Dore GJ
    J Infect Dis; 2020 Nov; 222(Suppl 9):S758-S772. PubMed ID: 33245354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 17. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Wyles DL; Sulkowski MS; Dieterich D
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S3-S11. PubMed ID: 27363438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Diagnosis and the Holy Grail.
    Applegate TL; Fajardo E; Sacks JA
    Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons Learned From Global Hepatitis C Elimination Programs.
    Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
    J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.